Pharmacology at Yale
The Department of Pharmacology strives to create an inviting environment and institutional culture of inclusivity where every individual's unique and diverse characteristics are valued and respected. We sustain the richness of our department by recruiting and retaining trainees, staff, and faculty from diverse backgrounds and talents.
Pharmacology at Yale University has a rich history of pre-eminence in drug discovery, indeed the first cancer chemotherapy clinical trials were conducted here. Today, the research in our department encompasses a broad range of fields, with researchers aiming to both understand and treat human disease.
About Us
Pharmacology at Yale University has a rich history of achievement and a strong tradition of scholarship. Yale was the site of the first studies and trials of anticancer chemotherapy. The modern era of cancer chemotherapy began when Alfred Gilman and Louis Goodman studied the effects of nitrogen mustard on transplanted lymphosarcoma in mice and then initiated clinical trials in 1942 (Gilman, A. Am. J. Surg. 105: 574-578, 1963).Research
Research in pharmacology covers many areas and uses many techniques, but underlying this diversity is a common theme--the investigation of the interaction of chemical substances with biological systems. Our research programs span from the atomic-level to the whole organism, and are highly collaborative within the department and throughout Yale.Read MorePharmacology Graduate Program
The Department of Pharmacology at Yale University offers integrated and interdisciplinary opportunities for graduate study under the Program in Biological and Biomedical Sciences (BBS). Students entering the BBS program can take courses, participate in laboratory rotations, and perform thesis research with any of the more than 200 faculty members in the biological sciences at Yale.
Read More
Latest News from the Department of Pharmacology
- November 11, 2024
Yale Cancer Answers with Dr. Joseph Contessa: Using Radiation to Treat Rare Brain Tumors
- November 07, 2024
Peripheral Sodium Channel Blocker Could Revolutionize Treatment for Nerve Pain
- October 03, 2024
A Promising Injectable for HIV Prevention
- September 12, 2024Source: CNN
Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill
- August 21, 2024Source: ASBMB Today
ASBMB names 2025 award winners
- August 09, 2024
Botanical Medicine Reduces Rectal Cancer Treatment Side Effects That Can Sideline Surgeries
- July 09, 2024
Yale Researchers Pave Way To Target Autoimmune Disease-associated Gene Variant
- May 31, 2024Source: Yale News
This Well-timed ‘Chameleon’ Sneaks up on Drug-resistant Brain Cancers
- May 08, 2024Source: Yale News
Getting to Know the Enzymes Behind Cell Communication — and Tumor Growth
Department of Pharmacology Events
Yale Only Wei Mi
Everyone Timothy Springer, PhD
Yale Only Speakers to be announced.
Yale Only Titus Boggon, PhD
Yale Only Stavroula Hatzios, PhD
Yale Only Brendan Manning
Yale Only Sloan Devlin
Yale Only Ed Boyden
Everyone
Yale Only Linda Van Aelst